All In Biotech

Free tool

FAERS Monitor: Exforge

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021990 or its brand name (Exforge, Amlodipine Besylate, Valsartan). Reports on generic versions are filed under their own applications.

Reports

11,054

Serious

9,506

86% of reports

Hospitalization

3,884

Death reported

1,273

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood pressure increased662
  • hypertension589
  • drug ineffective553
  • dizziness495
  • malaise471
  • death470
  • fatigue445
  • fall430
  • headache401
  • dyspnoea364
  • oedema peripheral354
  • diabetes mellitus353
  • diarrhoea345
  • cerebrovascular accident343
  • nausea327

Reports by year received

View as table
YearReports
200758
2008276
2009478
2010542
2011873
20121,107
2013885
2014812
2015776
2016683
2017593
2018759
2019612
2020599
2021548
2022469
2023347
2024238
2025214
2026185

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,105 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diabetes mellitusSignal3538.88.02,447
blood pressure increasedSignal6628.37.74,236
oedema peripheralSignal3545.55.01,316
hypertensionSignal5895.34.92,068
cerebrovascular accidentSignal3433.93.5728
fallSignal4302.52.2377
malaiseSignal4712.01.9255
dizziness4951.91.7211
dyspnoea3641.21.115
headache4011.21.116
fatigue4451.11.03
death4701.01.01
diarrhoea3451.00.90
drug ineffective5530.80.730
nausea3270.80.720

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.